中国医学创新Issue(28)：76-78,79,4.DOI:10.3969/j.issn.1674-4985.2014.28.027
脾氨肽（复可托）治疗小儿反复呼吸道感染的临床疗效观察
Clinical Observation Spleen Aminopeptidase(Stoeckel care)Treatment of Recurrent Respiratory Tract ;Infections
曾胜荣 1丁淑娟1
作者信息
- 1. 江西省抚州市第一人民医院 江西 抚州 344000
- 折叠
摘要
Abstract
Objective:To investigate the spleen ammonia peptide(complex)clinical curative effect for the treatment of recurrent respiratory tract infections. Method:To select 60 patients admitted in our hospital in recent years, patients with recurrent respiratory tract infections as the research object,according to the digital lottery method were randomly divided into research group and control group,30 cases in each group,the team in uplink compound could be the basis of routine therapy treatment,the control group only routine treatment,compare therapeutic effect of the two groups. Result:Team treatment efficiency was 56.7%,total effective rate was 90.0%,the control group’s treatment efficiency was 23.3%,total effective rate was 50.0%,the team with the treatment effect was better than the control group (P<0.05). Compared with before treatment,the team CD8 index after treatment in patients with decreased obviously, CD3,CD4,CD4/CD8 indicators appeared obvious rise,before and after treatment group patients with T cell subgroup index comparison difference was statistically significant(P<0.05). Conclusion:Compound can improve the patients' immune treatment of recurrent respiratory tract infections is imbalance,has significant clinical effect.关键词
脾氨肽/小儿反复呼吸道感染/免疫失衡Key words
Spleen aminopeptidase/Recurrent respiratory infections/Immune imbalance引用本文复制引用
曾胜荣,丁淑娟..脾氨肽（复可托）治疗小儿反复呼吸道感染的临床疗效观察[J].中国医学创新,2014,(28):76-78,79,4.
